Depression comorbidity in spinocerebellar ataxia - PubMed (original) (raw)
doi: 10.1002/mds.23698. Epub 2011 Mar 21.
Mathieu Coudert, Sophie Tezenas du Montcel, Paola Giunti, Robyn Labrum, Alexandra Dürr, Pascale Ribai, Perrine Charles, Christoph Linnemann, Ludger Schöls, Maryla Rakowicz, Rafal Rola, Elszbieta Zdzienicka, Roberto Fancellu, Caterina Mariotti, Lazlo Baliko, Bela Melegh, Alessandro Filla, Elena Salvatore, Bart P C van de Warrenburg, Sandra Szymanski, Jon Infante, Dagmar Timmann, Sylvia Boesch, Chantal Depondt, Jun-Suk Kang, Jörg B Schulz, Thomas Klopstock, Nicole Lossnitzer, Bernd Löwe, Caroline Frick, Daniela Rottländer, Thomas E Schlaepfer, Thomas Klockgether
Affiliations
- PMID: 21437988
- DOI: 10.1002/mds.23698
Depression comorbidity in spinocerebellar ataxia
Tanja Schmitz-Hübsch et al. Mov Disord. 2011 Apr.
Abstract
This is a description of the prevalence and profile of depressive symptoms in dominant spinocerebellar ataxia (SCA). Depressive symptoms were assessed in a convenience sample of 526 genetically confirmed and clinically affected patients (117 SCA1, 163 SCA2, 139 SCA3, and 107 SCA6) using the Patient Health Questionnaire (PHQ). In addition, depressive status according to the examiner and the use of antidepressants was recorded. Depression self-assessment was compared with an interview-based psychiatric assessment in a subset of 26 patients. Depression prevalence estimates were 17.1% according to the PHQ algorithm and 15.4% when assessed clinically. The sensitivity of clinical impression compared with PHQ classification was low (0.35), whereas diagnostic accuracy of PHQ compared with psychiatric interview in the subset was high. Antidepressants were used by 17.7% of patients and in >10% of patients without current clinically relevant depressive symptoms. Depression profile in SCA did not differ from a sample of patients with major depressive disorder except for the movement-related item. Neither depression prevalence nor use of antidepressants differed between genetic subtypes, with only sleep disturbance more common in SCA3. In a multivariate analysis, ataxia severity and female sex independently predicted depressive status in SCA. The PHQ algorithmic classification is appropriate for use in SCA but should stimulate further psychiatric evaluation if depression is indicated. Despite a higher risk for depression with more severe disease, the relation of depressive symptoms to SCA neurodegeneration remains to be shown.
Copyright © 2011 Movement Disorder Society.
Similar articles
- Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Schöls L, Zdienicka E, Kang JS, Döhlinger S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, di Donato S, du Montcel ST, Klockgether T. Schmitz-Hübsch T, et al. Neurology. 2008 Sep 23;71(13):982-9. doi: 10.1212/01.wnl.0000325057.33666.72. Epub 2008 Aug 6. Neurology. 2008. PMID: 18685131 - Depression and clinical progression in spinocerebellar ataxias.
Lo RY, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, Yu JT, Lee LE, Ashizawa T, Subramony SH, Kuo SH. Lo RY, et al. Parkinsonism Relat Disord. 2016 Jan;22:87-92. doi: 10.1016/j.parkreldis.2015.11.021. Epub 2015 Nov 22. Parkinsonism Relat Disord. 2016. PMID: 26644294 Free PMC article. - Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
Lee WY, Jin DK, Oh MR, Lee JE, Song SM, Lee EA, Kim GM, Chung JS, Lee KH. Lee WY, et al. Arch Neurol. 2003 Jun;60(6):858-63. doi: 10.1001/archneur.60.6.858. Arch Neurol. 2003. PMID: 12810491 Clinical Trial. - Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.
Rüb U, Del Turco D, Del Tredici K, de Vos RA, Brunt ER, Reifenberger G, Seifried C, Schultz C, Auburger G, Braak H. Rüb U, et al. Brain. 2003 Oct;126(Pt 10):2257-72. doi: 10.1093/brain/awg234. Epub 2003 Jul 7. Brain. 2003. PMID: 12847080 Review. - Parkinsonism in spinocerebellar ataxia.
Park H, Kim HJ, Jeon BS. Park H, et al. Biomed Res Int. 2015;2015:125273. doi: 10.1155/2015/125273. Epub 2015 Mar 19. Biomed Res Int. 2015. PMID: 25866756 Free PMC article. Review.
Cited by
- Autosomal dominant hereditary ataxia in Sri Lanka.
Sumathipala DS, Abeysekera GS, Jayasekara RW, Tallaksen CM, Dissanayake VH. Sumathipala DS, et al. BMC Neurol. 2013 May 1;13:39. doi: 10.1186/1471-2377-13-39. BMC Neurol. 2013. PMID: 23634774 Free PMC article. - Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3.
Maas RPPWM, Schutter DJLG, van de Warrenburg BPC. Maas RPPWM, et al. Cerebellum. 2021 Dec;20(6):887-895. doi: 10.1007/s12311-021-01252-9. Epub 2021 Mar 10. Cerebellum. 2021. PMID: 33694049 Free PMC article. - Extra-Cerebellar Signs and Non-motor Features in Chinese Patients With Spinocerebellar Ataxia Type 3.
Yuan X, Ou R, Hou Y, Chen X, Cao B, Hu X, Shang H. Yuan X, et al. Front Neurol. 2019 Feb 18;10:110. doi: 10.3389/fneur.2019.00110. eCollection 2019. Front Neurol. 2019. PMID: 30833927 Free PMC article. - Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
Feil K, Adrion C, Teufel J, Bösch S, Claassen J, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Stendel C, Uslar E, van de Warrenburg B, Berger I, Naumann I, Bayer O, Müller HH, Mansmann U, Strupp M. Feil K, et al. BMC Neurol. 2017 Jan 10;17(1):7. doi: 10.1186/s12883-016-0786-x. BMC Neurol. 2017. PMID: 28068987 Free PMC article. Clinical Trial. - Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review.
Almeida-Silva UC, Hallak JE, Júnior WM, Osório Fde L. Almeida-Silva UC, et al. Am J Neurodegener Dis. 2013 Jun 21;2(2):57-69. Print 2013. Am J Neurodegener Dis. 2013. PMID: 23844332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials